BioCardia, Inc. Increase (Decrease) in Restricted Cash
BioCardia, Inc. (BCDA) reported Increase (Decrease) in Restricted Cash of $0 for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2014-03-24
- BioCardia, Inc. increase (decrease) in restricted cash for the quarter ending 2013-12-31 was $0.00.
- BioCardia, Inc. increase (decrease) in restricted cash for the quarter ending 2013-09-30 was $0.00.
- BioCardia, Inc. increase (decrease) in restricted cash for the quarter ending 2012-12-31 was $0.00.
- BioCardia, Inc. increase (decrease) in restricted cash for the quarter ending 2012-09-30 was $0.00.
- BioCardia, Inc. increase (decrease) in restricted cash for fiscal 2013 was $0.00.
- BioCardia, Inc. increase (decrease) in restricted cash for fiscal 2012 was -$900.00K, a 200.00% decline from fiscal 2011.
- BioCardia, Inc. increase (decrease) in restricted cash for fiscal 2011 was $900.00K.
- BioCardia, Inc. increase (decrease) in restricted cash for fiscal 2010 was $0.00.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-24 | $0.00 derived: sum of 2 quarters · filed 2014-03-24 | $0.00 10-K · filed 2014-03-24 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $0.00 10-Q · filed 2013-11-01 | ||
| 2013-06-30 | $0.00 10-Q · filed 2013-07-26 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-24 | $0.00 derived: sum of 2 quarters · filed 2014-03-24 | -$900.00K 10-K · filed 2014-03-24 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | -$900.00K 10-Q · filed 2013-11-01 | ||
| 2012-06-30 | -$900.00K 10-Q · filed 2013-07-26 | |||
| 2011-12-31 | -$319.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | -$559.00K derived: sum of 2 quarters · filed 2013-03-22 | $900.00K 10-K · filed 2013-03-22 | |
| 2011-09-30 | -$240.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $1.22M 10-Q · filed 2012-11-08 | ||
| 2011-06-30 | $1.46M 10-Q · filed 2012-08-10 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $0.00 derived: sum of 2 quarters · filed 2012-03-29 | $0.00 10-K · filed 2012-03-29 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-15 | $0.00 10-Q · filed 2011-11-15 | ||
| 2010-06-30 | $0.00 10-Q/A · filed 2011-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |